Immunopharmacology and Immunotoxicology

Top Research Topics at Immunopharmacology and Immunotoxicology?

The journal was organized to reinforce research efforts on Immunology, Pharmacology, Internal medicine, Immune system and Endocrinology. The Immunology study featured in it draws connections with the study of In vitro. Immunopharmacology and Immunotoxicology tackles studies in Biochemistry and the interrelated subject of Molecular biology to gain insights into Pharmacology.

Topics in Molecular biology were tackled in line with various other fields like Cell culture and Apoptosis. It connects the study in Internal medicine with the closely related area of Gastroenterology. The concepts on Immune system presented in Immunopharmacology and Immunotoxicology can also apply to other research fields, including Spleen, Lymphocyte and Antigen.

The journal features studies on Endocrinology, including topics such as Ratón. Tumor necrosis factor alpha research presented in it encompasses a variety of subjects, including Proinflammatory cytokine and Interleukin. Cytokine research is the primary subject tackled in Immunopharmacology and Immunotoxicology with a focus on Interleukin 2.

• Immunology (37.87%)
• Pharmacology (24.16%)
• Internal medicine (21.91%)

What are the most cited papers published in the journal?

• CD69 and regulation of the immune function. (199 citations)
• Biomarkers of oxidative stress in ruminant medicine (169 citations)
• IMMUNOSTIMULATING EFFECTS OF ACIDIC POLYSACCHARIDES EXTRACT OF PANAX GINSENG ON MACROPHAGE FUNCTION (155 citations)

Research areas of the most cited articles at Immunopharmacology and Immunotoxicology:

The most cited articles mainly tackle studies in Immunology, Pharmacology, Immune system, Internal medicine and Endocrinology. Immunology study tackled in the journal articles is connected to the field of Cytotoxicity. The journal publications tackle studies in In vivo and the interrelated subject of In vitro to gain insights into Pharmacology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Enzyme
• Gene

The previous edition focused in particular on these issues:

The discussions in the journal mainly cover the fields of Inflammation, Cancer research, Pharmacology, Immunology and Immune system. The research on Inflammation tackled can also make contributions to studies in the areas of Anti-inflammatory and Lipopolysaccharide, Endocrinology. While the journal focused on Cancer research, it was also able to explore topics like Apoptosis, NF-κB, microRNA and PTEN.

Pharmacology research featured in Immunopharmacology and Immunotoxicology incorporates concerns from various other topics such as Immunosuppression, Cyclophosphamide, Toxicity and Hypoxia (medical). It links adjacent topics like Immunology with Receptor. The studies on Immune system discussed can also contribute to research in the domains of Immunoglobulin E, Autoimmune disease and Pathogenesis.

The most cited articles from the last journal are:

• Future perspective: biologic agents in patients with severe COVID-19. (8 citations)
• Deciphering Vaccines for COVID-19: where do we stand today? (7 citations)
• Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Immunopharmacology and Immunotoxicology (based on the number of publications) are:

• Emilio Jirillo (57 papers) absent at the last edition,
• Hyung-Min Kim (57 papers) absent at the last edition,
• Hyun-Ja Jeong (30 papers) absent at the last edition,
• Abbas Mirshafiey (29 papers) published 2 papers at the last edition the same number as at the previous edition,
• Han-Jung Chae (28 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Immunopharmacology and Immunotoxicology (based on the number of publications) are:

• University of Bari (161 papers) absent at the last edition,
• Wonkwang University (124 papers) absent at the last edition,
• Kyung Hee University (71 papers) absent at the last edition,
• Tehran University of Medical Sciences (50 papers) published 4 papers at the last edition, 4 less than at the previous edition,
• Chonbuk National University (48 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.76% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 6.76% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.41% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 9.46% of all publications and 78.38% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.